Xanodyne Pharmaceuticals, Inc.Newport, KY, United States
(NASDAQ (GM): XANO Proposed)
Today's Special Offer
Xanodyne Pharmaceuticals Financial Statements
Xanodyne Pharmaceuticals Financial Information
| Company Type |
Private
Headquarters |
| Fiscal Year-End |
December |
Xanodyne Pharmaceuticals Income Statement
| Revenue ($ mil.) |
66.9 |
52.6 |
13.7 |
| Gross Profit ($ mil.) |
53.4 |
42.5 |
8.8 |
| Operating Income ($ mil.) |
(23.2) |
(119.7) |
(43.1) |
| Total Net Income ($ mil.) |
(28.3) |
(122.4) |
(42.5) |
| Diluted EPS (Net Income) |
-- |
-- |
-- |
